372 related articles for article (PubMed ID: 24836189)
21. Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment.
Leite ML; da Cunha NB; Costa FF
Pharmacol Ther; 2018 Mar; 183():160-176. PubMed ID: 29024740
[TBL] [Abstract][Full Text] [Related]
22. Anticancer mechanism of peptide P18 in human leukemia K562 cells.
Tang C; Shao X; Sun B; Huang W; Qiu F; Chen Y; Shi YK; Zhang EY; Wang C; Zhao X
Org Biomol Chem; 2010 Mar; 8(5):984-7. PubMed ID: 20165784
[TBL] [Abstract][Full Text] [Related]
23. [Enhancement of cytotoxicity of cantionic antimicrobial peptide in tumor cells by conjugation to cell-penetrating peptide].
Liu S; Yang H; Cai H; Wan L; Lu X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Feb; 28(1):110-4. PubMed ID: 21485195
[TBL] [Abstract][Full Text] [Related]
24. Insect antimicrobial peptides: potential tools for the prevention of skin cancer.
Tonk M; Vilcinskas A; Rahnamaeian M
Appl Microbiol Biotechnol; 2016 Sep; 100(17):7397-405. PubMed ID: 27418360
[TBL] [Abstract][Full Text] [Related]
25. Anticancer activity of undecapeptide analogues derived from antimicrobial peptide, brevinin-1EMa.
Kang SJ; Ji HY; Lee BJ
Arch Pharm Res; 2012 May; 35(5):791-9. PubMed ID: 22644847
[TBL] [Abstract][Full Text] [Related]
26. Anticancer mechanisms of temporin-1CEa, an amphipathic α-helical antimicrobial peptide, in Bcap-37 human breast cancer cells.
Wang C; Zhou Y; Li S; Li H; Tian L; Wang H; Shang D
Life Sci; 2013 May; 92(20-21):1004-14. PubMed ID: 23583573
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF(32-51) region.
Vallespi MG; Fernandez JR; Torrens I; Garcia I; Garay H; Mendoza O; Granadillo M; Falcon V; Acevedo B; Ubieta R; Guillen GE; Reyes O
J Pept Sci; 2010 Jan; 16(1):40-7. PubMed ID: 19908203
[TBL] [Abstract][Full Text] [Related]
28. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
[TBL] [Abstract][Full Text] [Related]
29. Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.
Lin MC; Hui CF; Chen JY; Wu JL
Peptides; 2013 Jun; 44():139-48. PubMed ID: 23598079
[TBL] [Abstract][Full Text] [Related]
30. Exploiting the human peptidome for novel antimicrobial and anticancer agents.
Bosso M; Ständker L; Kirchhoff F; Münch J
Bioorg Med Chem; 2018 Jun; 26(10):2719-2726. PubMed ID: 29122440
[TBL] [Abstract][Full Text] [Related]
31. Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.
Yang QZ; Wang C; Lang L; Zhou Y; Wang H; Shang DJ
Arch Pharm Res; 2013 Nov; 36(11):1302-10. PubMed ID: 23609760
[TBL] [Abstract][Full Text] [Related]
32. Anti-melanoma activity of hybrid peptide P18 and its mechanism of action.
Huang W; Lu L; Shao X; Tang C; Zhao X
Biotechnol Lett; 2010 Apr; 32(4):463-9. PubMed ID: 19957017
[TBL] [Abstract][Full Text] [Related]
33. Designed antimicrobial and antitumor peptides with high selectivity.
Hu J; Chen C; Zhang S; Zhao X; Xu H; Zhao X; Lu JR
Biomacromolecules; 2011 Nov; 12(11):3839-43. PubMed ID: 21955251
[TBL] [Abstract][Full Text] [Related]
34. Magnetic nanoparticles: new players in antimicrobial peptide therapeutics.
López-Abarrategui C; Figueroa-Espí V; Reyes-Acosta O; Reguera E; Otero-Gonzalez AJ
Curr Protein Pept Sci; 2013 Nov; 14(7):595-606. PubMed ID: 23968342
[TBL] [Abstract][Full Text] [Related]
35. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
36. Application Value of Antimicrobial Peptides in Gastrointestinal Tumors.
Liu Q; Wang L; He D; Wu Y; Liu X; Yang Y; Chen Z; Dong Z; Luo Y; Song Y
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069041
[TBL] [Abstract][Full Text] [Related]
37. Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.
Riedl S; Zweytick D; Lohner K
Chem Phys Lipids; 2011 Nov; 164(8):766-81. PubMed ID: 21945565
[TBL] [Abstract][Full Text] [Related]
38. Applications of antimicrobial peptides from fish and perspectives for the future.
Rajanbabu V; Chen JY
Peptides; 2011 Feb; 32(2):415-20. PubMed ID: 21093512
[TBL] [Abstract][Full Text] [Related]
39. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
Moretti L; Yang ES; Kim KW; Lu B
Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
[TBL] [Abstract][Full Text] [Related]
40. Recent Progress in Machine Learning-based Prediction of Peptide Activity for Drug Discovery.
Wu Q; Ke H; Li D; Wang Q; Fang J; Zhou J
Curr Top Med Chem; 2019; 19(1):4-16. PubMed ID: 30674262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
